108 related articles for article (PubMed ID: 16434901)
1. Increased occurrence of caspase-dependent apoptosis in unfavorable neuroblastomas.
Koizumi H; Hamano S; Doi M; Tatsunami S; Nakada K; Shinagawa T; Tadokoro M
Am J Surg Pathol; 2006 Feb; 30(2):249-57. PubMed ID: 16434901
[TBL] [Abstract][Full Text] [Related]
2. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression.
Kitanaka C; Kato K; Ijiri R; Sakurada K; Tomiyama A; Noguchi K; Nagashima Y; Nakagawara A; Momoi T; Toyoda Y; Kigasawa H; Nishi T; Shirouzu M; Yokoyama S; Tanaka Y; Kuchino Y
J Natl Cancer Inst; 2002 Mar; 94(5):358-68. PubMed ID: 11880474
[TBL] [Abstract][Full Text] [Related]
3. Ras protein expression and autophagic tumor cell death in neuroblastoma.
Kitanaka C; Kato K; Tanaka Y
Am J Surg Pathol; 2007 Jan; 31(1):153-5; author reply 155-7. PubMed ID: 17197932
[No Abstract] [Full Text] [Related]
4. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
6. Implication of unfavorable histology, MYCN amplification and diploidy for stage I and II neuroblastomas.
de Buys Roessingh AS; Rougemont AL; Wiesenauer C; Barrette S; Bouron-Dal Soglio D; Lallier M
Eur J Pediatr Surg; 2008 Dec; 18(6):410-4. PubMed ID: 19012235
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
[TBL] [Abstract][Full Text] [Related]
8. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak H; Ackermann S; Hero B; Kahlert Y; Oberthuer A; Juraeva D; Roels F; Theissen J; Westermann F; Deubzer H; Ehemann V; Brors B; Odenthal M; Berthold F; Fischer M
Cell Death Dis; 2013 Apr; 4(4):e586. PubMed ID: 23579273
[TBL] [Abstract][Full Text] [Related]
9. Caspase 3 and 8 deficiency in human neuroblastoma.
Iolascon A; Borriello A; Giordani L; Cucciolla V; Moretti A; Monno F; Criniti V; Marzullo A; Criscuolo M; Ragione FD
Cancer Genet Cytogenet; 2003 Oct; 146(1):41-7. PubMed ID: 14499695
[TBL] [Abstract][Full Text] [Related]
10. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
[TBL] [Abstract][Full Text] [Related]
11. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH
Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458
[TBL] [Abstract][Full Text] [Related]
12. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death.
Teitz T; Lahti JM; Kidd VJ
J Mol Med (Berl); 2001 Aug; 79(8):428-36. PubMed ID: 11511973
[TBL] [Abstract][Full Text] [Related]
13. Ataxin-2 promotes apoptosis of human neuroblastoma cells.
Wiedemeyer R; Westermann F; Wittke I; Nowock J; Schwab M
Oncogene; 2003 Jan; 22(3):401-11. PubMed ID: 12545161
[TBL] [Abstract][Full Text] [Related]
14. Geldanamycin decreases Raf-1 and Akt levels and induces apoptosis in neuroblastomas.
Kim S; Kang J; Hu W; Evers BM; Chung DH
Int J Cancer; 2003 Jan; 103(3):352-9. PubMed ID: 12471618
[TBL] [Abstract][Full Text] [Related]
15. High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma.
Sartelet H; Ohta S; Barrette S; Rougemont AL; Brevet M; Regairaz M; Harvey I; Bernard C; Fabre M; Gaboury L; Oligny LL; Bosq J; Valteau-Couanet D; Vassal G
Histopathology; 2010 Apr; 56(5):607-16. PubMed ID: 20459571
[TBL] [Abstract][Full Text] [Related]
16. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.
Cortés C; Kozma SC; Tauler A; Ambrosio S
Cell Oncol (Dordr); 2015 Oct; 38(5):341-52. PubMed ID: 26306783
[TBL] [Abstract][Full Text] [Related]
17. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
[TBL] [Abstract][Full Text] [Related]
18. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
[TBL] [Abstract][Full Text] [Related]
20. Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma.
Fulda S; Poremba C; Berwanger B; Häcker S; Eilers M; Christiansen H; Hero B; Debatin KM
Cancer Res; 2006 Oct; 66(20):10016-23. PubMed ID: 17047064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
